Celldex Therapeutics Inc. - Return On Capital (Last 12 Months) - MarketXLS
Data
Return On Capital (Last 12 Months)
Live-27.86
Returns the company's net income for the past 12 months divided by its total capital.
How calculated | It is calculated by dividing net profit generated in last 12 months by sum of total equity and long term liabilities in the balance sheet |
Example usage | =ReturnOnCapitalLTM("MSFT") |
Assets | Stocks |
| Stock | Return On Capital (Last 12 Months) |
|---|---|
CLDX | -27.86 |
EBS | -34.09 |
AMGN | 4.57 |
PFE | -50.55 |
TTNP | -352.98 |
Celldex Therapeutics Inc.
CLDX 
NSC
Sector: Healthcare
Industry: Biotechnology
25.68
USD
-0.38
(-1.46%)
Previous close: 26.06 Open: 25.91 Bid: 25.25 Ask: 30.0
52 week range
25.08 53.18
Mkt Cap: 1,780 M Avg Vol (90 Days): 1,019,826
Last updated: Monday 4th November 2024
Call: 1-877-778-8358 
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS is a complete Excel stock solution
I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel
MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.
I like to access historical closing prices on a particular date. That makes tracking performance easy.